CHF Solutions Expands Intellectual Property Portfolio with Two New Patent Filings for Innovations to Aquadex FlexFlow® System
“CHF Solutions has long remained dedicated to innovation of its technology and optimizing the application of our Aquadex FlexFlow system for the treatment of fluid overload in a variety of settings,” said
One of the two applications is based on the company’s design for a wearable device designed to assist in maintaining peripheral venous blood flow access in the arm during aquapheresis treatment with the Aquadex FlexFlow system. The second application includes multiple potential new features and improvements to the diagnostic capabilities of the Aquadex FlexFlow system, which, if incorporated into the product, would be designed to help ensure optimal patient fluid balance and to dramatically improve usability for healthcare providers.
About CHF Solutions
Forward-Looking Statements
Certain statements in this release may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation, the ability of the design features contained in the patents to improve product performance. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including, without limitation, those risk associated with our ability to execute on our commercial strategy, the possibility that we may be unable to raise sufficient funds necessary for our anticipated operations, our post-market clinical data collection activities, benefits of our products to patients, our expectations with respect to product development and commercialization efforts, our ability to increase market and physician acceptance of our products, potentially competitive product offerings, intellectual property protection, our ability to integrate acquired businesses, our expectations regarding anticipated synergies with and benefits from acquired businesses, and other risks and uncertainties described in our filings with the SEC. Forward-looking statements speak only as of the date when made. CHF Solutions does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACTS:
INVESTORS:
Chief Financial Officer
952-345-4205
ir@chf-solutions.com
-or-
Managing Partner
CORE IR
516-222-2560
brets@coreir.com
www.coreir.com
MEDIA
917-885-7378
jabraham@jqapartners.com
Source: CHF Solutions, Inc.